הכנסה תפעולית לפני ניכוי פחת: onconetix.gcs-web.com (ONCO)

Onconetix, Inc. (ONCO) is expanding its market presence through partnerships with urological centers, scaling the distribution of its therapeutic systems. The EBITDA_Co trend, with a value currently at 0.00, links this growth to diversification into prostate diagnostics and hormone therapy. However, small operational volumes create a fragile cash flow, despite existing demand for men's health products.

Selecting assets with a high margin of safety begins with analyzing a business's ability to generate real cash flow before depreciation and interest. This metric measures net operating income, allowing for an assessment of the effectiveness of the Onconetix, Inc. (ONCO) customer base restructuring and the demand for men's health products through EBITDA cash flow dynamics.